Stuart A. Fine serves as Executive at AKESIS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Stuart A. Fine has executed 8 insider transactions totaling $184.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 23, 2008 involved purchasing 5,000 shares valued at $2.5K.
Stuart A. Fine currently holds 202,401 shares of AKESIS PHARMACEUTICALS, INC. (AKES.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart A. Fine has been a net buyer of AKES.OB stock. They have purchased $184.7K and sold $0 worth of shares.
Stuart A. Fine's most recent insider trade was on Sep 23, 2008, when they purchased 5,000 shares at $0.49 per share.
Get notified when new Form 4 filings are submitted
| $0.80 |
| Discretionary |
| Aug 1, 2008 | AKES.OB | $39.2K | Purchase | 42,101 | $0.93 | Discretionary |
| Aug 1, 2008 | AKES.OB | $16.1K | Purchase | 19,000 | $0.85 | Discretionary |
| Jul 28, 2008 | AKES.OB | $104.5K | Purchase | 110,050 | $0.95 | Discretionary |
| Jul 24, 2008 | AKES.OB | $2.0K | Purchase | 2,500 | $0.80 | Discretionary |
| Jul 24, 2008 | AKES.OB | $7.8K | Purchase | 10,000 | $0.78 | Discretionary |
| Jul 24, 2008 | AKES.OB | $10.6K | Purchase | 11,250 | $0.94 | Discretionary |